IL-2-based Immunotherapy After Autologous Transplantation for Lymphoma and Breast Cancer Induces Immune Activation and Cytokine Release: A Phase I/Ii Trial

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704086

Related search